These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10413018)

  • 41. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
    Mueller A; Reuner U; Landis B; Kitzler H; Reichmann H; Hummel T
    Mov Disord; 2006 Sep; 21(9):1311-6. PubMed ID: 16763975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation.
    Gutierrez D; Montandon ML; Assal F; Allaoua M; Ratib O; Lövblad KO; Zaidi H
    Comput Med Imaging Graph; 2012 Dec; 36(8):610-9. PubMed ID: 23046730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetic resonance spectroscopy (MRS) in five patients with treated propionic acidemia.
    Chemelli AP; Schocke M; Sperl W; Trieb T; Aichner F; Felber S
    J Magn Reson Imaging; 2000 Jun; 11(6):596-600. PubMed ID: 10862057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aceruloplasminemia: a multimodal imaging study in an Italian family with a novel mutation.
    Salsone M; Arabia G; Annesi G; Gagliardi M; Nistico R; Novellino F; Ferini-Strambi L; Quattrone A; Quattrone A
    Neurol Sci; 2022 Mar; 43(3):1791-1797. PubMed ID: 34559338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical role of positron emission tomography in children with tuberous sclerosis complex.
    Rintahaka PJ; Chugani HT
    J Child Neurol; 1997 Jan; 12(1):42-52. PubMed ID: 9010795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroimaging in infantile autism.
    Schifter T; Hoffman JM; Hatten HP; Hanson MW; Coleman RE; DeLong GR
    J Child Neurol; 1994 Apr; 9(2):155-61. PubMed ID: 8006366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
    Blautzik J; Kotz S; Brendel M; Sauerbeck J; Vettermann F; Winter Y; Bartenstein P; Ishii K; Rominger A;
    J Alzheimers Dis; 2018; 65(3):781-791. PubMed ID: 28697560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.
    Vijverberg EG; Wattjes MP; Dols A; Krudop WA; Möller C; Peters A; Kerssens CJ; Gossink F; Prins ND; Stek ML; Scheltens P; van Berckel BN; Barkhof F; Pijnenburg YA
    J Alzheimers Dis; 2016 Jun; 53(4):1287-97. PubMed ID: 27372646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison between MRI-based attenuation correction methods for brain PET in dementia patients.
    Cabello J; Lukas M; Rota Kops E; Ribeiro A; Shah NJ; Yakushev I; Pyka T; Nekolla SG; Ziegler SI
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2190-2200. PubMed ID: 27094314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
    Kushner BH; Yeung HW; Larson SM; Kramer K; Cheung NK
    J Clin Oncol; 2001 Jul; 19(14):3397-405. PubMed ID: 11454888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Added Value of Including Entire Brain on Body Imaging With FDG PET/MRI.
    Franceschi AM; Matthews R; Bangiyev L; Relan N; Chaudhry A; Franceschi D
    AJR Am J Roentgenol; 2018 Jul; 211(1):176-184. PubMed ID: 29792727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.
    Hebert ME; Lowe VJ; Hoffman JM; Patz EF; Anscher MS
    Am J Clin Oncol; 1996 Aug; 19(4):416-21. PubMed ID: 8677917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positron emission tomography in presurgical localization of epileptic foci.
    Csaba J
    Ideggyogy Sz; 2003 Jul; 56(7-8):249-54. PubMed ID: 12971120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FDG PET brain scan demonstrated glucose hypometabolism of bilateral caudate nuclei and putamina in a patient with chorea-acanthocytosis.
    Cui R; You H; Niu N; Li F
    Clin Nucl Med; 2015 Dec; 40(12):979-80. PubMed ID: 26359566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebral (18)FluoroDeoxy-Glucose Positron Emission Tomography in paediatric anti N-methyl-D-aspartate receptor encephalitis: A case series.
    Lagarde S; Lepine A; Caietta E; Pelletier F; Boucraut J; Chabrol B; Milh M; Guedj E
    Brain Dev; 2016 May; 38(5):461-70. PubMed ID: 26542469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study.
    Tahmasian M; Shao J; Meng C; Grimmer T; Diehl-Schmid J; Yousefi BH; Förster S; Riedl V; Drzezga A; Sorg C
    J Nucl Med; 2016 Mar; 57(3):410-5. PubMed ID: 26585059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain FDG-PET: clinical use in dementing neurodegenerative conditions.
    Nobili F; Schmidt R; Carriò I; Frisoni GB
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1467-1469. PubMed ID: 29687206
    [No Abstract]   [Full Text] [Related]  

  • 58. FDG Brain PET/CT Revealing Bilateral Thalamostriatal Activation During a Symptomatic Episode in a Patient With Kleine-Levin Syndrome.
    Drouet C; Morel O; Verger A; Guedj E; Boulahdour H
    Clin Nucl Med; 2017 May; 42(5):e261-e262. PubMed ID: 28221196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MRI and 18F-fluorodeoxyglucose positron emission tomography in hemimegalencephaly.
    Hoffmann KT; Amthauer H; Liebig T; Hosten N; Etou A; Lehmann TN; Farahati J; Felix R
    Neuroradiology; 2000 Oct; 42(10):749-52. PubMed ID: 11110079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
    Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
    Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.